Instead, it results in increased expression of CCL2 in pericytes, which subsequently activates MEK1-ERK1/2-ROCK2 signaling in tumor cells, ultimately leading to accelerated tumor growth (Wong et al, 2020). Here, MAP2K1 is linked to neoplasm.